Hype checkGrade C — proceed with skepticism

Fisetin

A senolytic flavonoid with striking mouse data on clearing senescent cells, but human clinical trials are only just beginning — hype check candidate.

By editorialUpdated 2026-05-251 min read

The evidence isn't there yet.

A landmark 2018 mouse study showed fisetin was the most potent senolytic among 10 flavonoids tested, extending median lifespan even when given late in life. However, human clinical trials (including the ongoing AFFIRM trial at Mayo Clinic) have not yet reported definitive efficacy results.

What it's actually good for

Fisetin is a flavonoid found in strawberries, apples, and other fruits that has generated significant excitement in the longevity community since a 2018 study demonstrated it was the most effective senolytic compound among those tested in aged mice — clearing damaged senescent cells and extending lifespan even when administered late in life. The concept of senolytics (drugs that selectively kill zombie-like senescent cells that accumulate with age and drive inflammation) is one of the most scientifically compelling ideas in aging research. However, the jump from mouse studies to human benefit is where fisetin's story currently stalls. Oral bioavailability in humans is poor, and it is unclear whether achievable tissue concentrations are sufficient for senolytic activity. The Mayo Clinic's AFFIRM trials are testing fisetin in humans, but definitive results have not yet been published. Until those trials report, fisetin remains a fascinating preclinical compound that has not yet earned a recommendation for human use — the interest is justified, but the evidence is not yet there.

Claim-by-claim

Each claim graded independently

The overall grade is the floor. Some claims are stronger or weaker than the headline.

C

Fisetin clears senescent cells and extends healthspan

A landmark 2018 mouse study showed fisetin was the most potent senolytic among 10 flavonoids tested, extending median lifespan even when given late in life. However, human clinical trials (including the ongoing AFFIRM trial at Mayo Clinic) have not yet reported definitive efficacy results.

Sources

2 cited
[01]RCTAlleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults (AFFIRM-LITE) — trial registrationClinicalTrials.gov. 2021
[02]ANIMALFisetin is a senotherapeutic that extends health and lifespanYousefzadeh MJ, Zhu Y, McGowan SJ, et al.. EBioMedicine. 2018

When the evidence changes, we’ll tell you.

One short email a month. New A-grades, downgraded claims, and reader questions.

Medical disclaimer. The information on this site is provided for educational purposes only and is not intended as medical advice. It does not constitute a diagnosis, treatment plan, or recommendation for any specific health condition. Always consult a qualified healthcare professional before making changes to your supplement regimen, diet, or lifestyle — especially if you are pregnant, nursing, taking medications, or managing a medical condition.

Affiliate disclosure. Some links on this site are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. This never influences our editorial assessments — products are graded solely on the evidence.